Cell And Gene Therapies

Pic:getty/markrubens

BioNTech acquires GMP manufacturing site in Singapore

By Rachel Arthur

BioNTech will create an mRNA facility in Singapore through the acquisition of a Novartis site: which will become its Regional Headquarters and production center for the Asia Pacific region.

© GettyImages/Yuuji

Lonza expands team, labs for cell and gene development

By Jane Byrne

Lonza is to increase the size of the cell and gene therapy (CGT) development space at its Houston facility; the expansion will include viral vector-based process development and analytical development laboratories.

Pic:getty/dimitriotis

Philadelphia’s CGT sector highlights future talent needs

By Rachel Arthur

Employment in Greater Philadelphia among cell and gene therapy companies has more that doubled since 2019, while employees at contract manufacturing organizations have grown by nearly 40%. Continuing to build the workforce will be crucial as the area...

Pic:getty/chaluk

Matica Bio opens new Texas cell and gene therapy facility

By Rachel Arthur

CDMO Matica Bio has opened a new 45,000-square-foot facility dedicated to the production of viral vectors and cell-based products used in cell and gene therapies, vaccines, oncolytic therapies and other genetic medicines.

Pic:getty/richarddrury

Nurturing biotech in Europe: EuropaBio sets out recommendations

By Rachel Arthur

EU systems need to become more streamlined to help bring novel technologies to market - which would in turn encourage investment and activity in healthcare biotech, says EuropaBio as it publishes key policy recommendations for the sector.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers